When was GemPharmatech founded?

GemPharmatech was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is GemPharmatech located?

GemPharmatech is headquartered in Nanjing, China.

How many employees does GemPharmatech have?

As of Mar 31, 2026, the latest employee count at GemPharmatech is 106.

Is GemPharmatech a funded company?

GemPharmatech is a funded company, having raised a total of $81.9M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jul 02, 2019.

When was the latest funding round of GemPharmatech?

GemPharmatech's latest funding was a $***** Series B round on Sep 11, 2020, with participation from 5 investors.

Where does GemPharmatech rank among its competitors?

GemPharmatech ranks 4th amongst 45 active competitors, of which 8 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Sus Clinicals, which secured $2M in Sep, 2023.

Who are the top competitors of GemPharmatech?

GemPharmatech's top competitors include Applied StemCell, Biocytogen and Hera Biolabs. Among them, Sus Clinicals secured the most recent funding round in September, 2023.

GemPharmatech - 2026 Company Profile, Funding & Competitors

GemPharmatech is a public company based in Nanjing (China), founded in 2018. It operates as a Provider of humanized models and drug screening technologies. GemPharmatech has raised $81.9M in funding from investors like Morgan Stanley, CDH and Yunfeng Capital. The company has 45 active competitors, including 8 funded and 7 that have exited. Its top competitors include companies like Applied StemCell, Biocytogen and Hera Biolabs.

Company Details

Provider of humanized models and drug screening technologies. It offers research application for animal models for different drug and disease metabolism, functional analysis and evaluation, animal model like trasgenic mouse, ES gene editing and others. It also offers other technical services like cell-line, biological sample refrigeration and others.

Website: gempharmatech.com
Email ID: *****@gempharmatech.com
Phone Number: +86 **********

Key Metrics

Founded Year

2018

Location

Nanjing, China

Stage

Public

Total Funding

$81.9M in 2 rounds

Latest Funding Round

Series B, Sep 11, 2020, $*****

Investors

Morgan Stanley & 7 more

Ranked

4^th among 45 active competitors

Employee Count

106 as on Mar 31, 2026

Similar Companies

Applied StemCell & 56 more

Exit Details

Public

View GemPharmatech's full profile

GemPharmatech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
GEMPHARMATECH LLC CIN: 844915130 , United States, Active	Dec 31, 1999	-	17 (As on Dec 31, 2024)	-

GemPharmatech got listed on Apr 29, 2022.

Click here to take a look at GemPharmatech's IPO in detail

GemPharmatech has raised a total funding of $81.9M over 2 rounds. Its first funding round was on Jul 02, 2019. Its latest funding round was a Series B round on Sep 11, 2020 for $*****. 5 investors participated in its latest round. GemPharmatech has 8 institutional investors.

Here is the list of recent funding rounds of GemPharmatech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 11, 2020	1116243	Series B	4515427	3160459	1569169	8902525
Jul 02, 2019	1814172	Series A	2956752	1788376	CDH & 1 more	4123096

Access funding benchmarks and valuations. Sign up today!

View details of GemPharmatech's funding rounds and investors

GemPharmatech's employee count trend

GemPharmatech has 106 employees as of Mar 26. Here is GemPharmatech's employee count trend over the years:

Uncover GemPharmatech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GemPharmatech include Applied StemCell, Biocytogen and Hera Biolabs. Here is the list of Top 10 competitors of GemPharmatech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Applied StemCell 2008, Milpitas (United States), Acquired	Provider of animal and cell line models as tools for drug discovery and diagnostics	$67.5M	Advantech Capital, Fosun & 8 others	68/100
2nd	Biocytogen 2008, Wakefield (United States), Public	Provider of integrated solutions for next-generation antibody drug development	$301M	CMB International Capital, SDIC & 11 others	67/100
3rd	Hera Biolabs 2015, Lexington (United States), Acquired	Provider of rodent models for in vitro and in vivo safety and efficacy testing services	$3.39M	Enterprise Angels Community Fund I, Bluegrass Angels ... & 1 others	54/100
4th	GemPharmatech 2018, Nanjing (China), Public	Provider of humanized models and drug screening technologies	$81.9M	Yunfeng Capital, TF Capital & 6 others	58/100
5th	Business Catalyst 2004, San Jose (United States), Series A	-	$1.25M	Midven	46/100
6th	Sus Clinicals 2020, Cincinnati (United States), Series A	Provider of preclinical testing services using pig models	$3.7M	HHS	42/100
7th	Nagi Bioscience 2017, Lausanne (Switzerland), Seed	Developer of a organism on a chip based technology	$1.84M	Zurcher Kantonalbank, Verve Ventures & 2 others	38/100
8th	BioReperia 2015, Stockholm (Sweden), Series A	Develops animal model for oncology and toxicology	$882K	Almi Invest, LiU Invest & 4 others	37/100
9th	Lingfu Biotechnology 2021, Beijing (China), Seed	Animal research service provider that offers animal behavior analysis services	$30.8M	China Life Insurance, Legend Capital & 2 others	36/100
10th	ingenious targeting laboratory 1998, Ronkonkoma (United States), Funding Raised	Provider of custom gene targeting and mouse model services	-	Long Island High Technology Incubator, HHS	34/100